Matches in Nanopublications for { ?s ?p "[The prevailing view of cdk2 as a critical regulator of cell cycle progression and optimal therapeutic target in cancer cells is now challenged by the observation that tumor cells deficient in cdk2 protein and kinase activity are not impaired in proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP892068.RAeEga3atJA9smg2oUKqGEljIzsiMgPOcq87Owanv4Mqg130_assertion description "[The prevailing view of cdk2 as a critical regulator of cell cycle progression and optimal therapeutic target in cancer cells is now challenged by the observation that tumor cells deficient in cdk2 protein and kinase activity are not impaired in proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892068.RAeEga3atJA9smg2oUKqGEljIzsiMgPOcq87Owanv4Mqg130_provenance.
- NP892109.RAarwR0ovwL-x8xjPugBWY5ouHlE_qR-cyz_6LkkFGvhU130_assertion description "[The prevailing view of cdk2 as a critical regulator of cell cycle progression and optimal therapeutic target in cancer cells is now challenged by the observation that tumor cells deficient in cdk2 protein and kinase activity are not impaired in proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892109.RAarwR0ovwL-x8xjPugBWY5ouHlE_qR-cyz_6LkkFGvhU130_provenance.